MIRA INFORM REPORT

 

 

Report Date :           

16.06.2011

 

IDENTIFICATION DETAILS

 

Name :

BIOQUIFAR PHARMACEUTICA SA

 

 

Registered Office :

Cra. 37A Nº 25-52 Barrio El Recuerdo Bogota

 

 

Country :

Colombia

 

 

Date of Incorporation :

19.02.1992

 

 

Legal Form :

Sociedad Anonima

 

 

Line of Business :

Pharmaceuticals Products

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 50,000

Status :

Satisfactory

Payment Behaviour :

Usually Correct

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2011

 

Country Name

Previous Rating

                   (31.12.2010)                  

Current Rating

(31.03.2011)

Colombia

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 Bottom of Form

GEOPOLITICS - COLOMBIA

 

POLITICAL DATA

ECONOMIC DATA

Form of Government: Republic


Economic Risk: Low

Currency: 100.00 USD  = 177,500.00 COP

Branch Situation: Stable

 

 

IDENTIFICATION

 

Ordered as:

Bioquifar Pharmaceutica SA

Address in the order:

Carrea 37a No. 25-52 Bogota

Legal Name:

Bioquifar Pharmaceutica SA

Legal Address

Cra. 37A Nº 25-52 Barrio El Recuerdo Bogota Colombia.

Telephone:

+57-1-2686887

NIT :

800156213

Fax:

+57-1-3350605

Legal Form:

Sociedad Anonima

Email:

CONTABILIDAD@BIOQUIFAR.COM

Registered in:

Colombia

Website:

www.bioquifar.com (Under construction)

Date Created:

1992

Manager:

Gonzalez Camacho Luis Emiro, Legal representative

Date Incorporated:

February 19th, 1992

Staff:

40

Stock:

N/A

 

 

Value:

N/A

Activity:

Pharmaceuticals products

 

BANKS

 

Name of the Bank

Bancolumbia

 

 

BUSINESS

 

HISTORY

 

The company was created in the year 1992.

PRINCIPAL ACTIVITY

 

The company is categorized under pharmaceuticals laboratories.

Sales are:

 

Wholesale

Clients:

 

Various industries

Operations area:

 

National, International, Local

The company imports from Worldwide

The company export to Wordlwide, depending on the demand,

Competitors:

 

Proclin Pharma

Chemical Net SAS

Meicy's

Servicios Pharma Luz LTDA

Genfar SA

The subject employs 40 employee(s)

PAYMENTS

 

made on a 50 days basis - monitored over the last 12 months

LOCATION

Headquarters

 

The company is headquartered at Cra. 37A Nº 25-52 Barrio El Recuerdo Bogota Colombia.

Branches:

 

There were no branches found for this company.

 

Shareholders - Manager - Related Companies

 

Shareholders Parent Company(ies):

 

This is a privately held company. Despite our long searches it has not been possible to identify the shareholders.

Management:

 

Gonzalez Camacho Luis Emiro, Legal representative

Cañon Cadena Sandra Patricia, Tax Auditor

Olga Lucia Carranza Vivas, Accountant

 

 

Financials - COMMERCIAL TRENDS AND FORECAST

 

As a private company the subject does not publish any financial statements.

We have contacted Yolanda, who refused to provide us any financial data on grounds of confidentiality.

However our financial sources could provide us with the following data.

 

Those figures are estimates provided by confidential banking and financial institutions working with the company.

 

Currency

DATE

USD

2010

Turnover

3,300,000

Operating Income

100,000

Net Income

87,000

Net worth

540,000

Liabilities

100,000

The cash flow is

Normal

 

Legal Fillings

 The sources consulted record no detrimental legal or labor court information.

 

 

 

Rating

 

Local credit bureau gave a correct credit rate.

 

The company is in Good Standing. This means that all local and federal taxes were paid on due date.

 

 

 Final Opinion

 

This is a medium size company with 40 employees and 19 years of experience.

 

There were no legal filings found against the company or its legal representatives.

 

We've contacted the company but they refused to provide us any financial data on grounds of confidentiality.

 

 

Our financial sources provided us with the financial figures for the year 2010.

 

The company gave a correct profitability for the year 2010.

 

A credit line may be considered for USD 50,000

 



SUMMARY

 


FINANCIAL SUMMARY


DEBT COLLECTIONS AND PAYMENTS

Profitability

CORRECT

Public

NO

Indebtedness

CONTROLLED

Payments

REGULAR

Cash

NORMAL

 

 

 

 

 

 



 

 

 

 

APPENDIX

 

Person Interviewed

 

Yolanda

Position

 

Representative

Comments

 

She refused to provide us any financial data on grounds of confidentiality.

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.44.68

UK Pound

1

Rs.73.05

Euro

1

Rs.64.29

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.